Related references
Note: Only part of the references are listed.Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
David O'Connor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia
Franco Locatelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
N. Hijiya et al.
LEUKEMIA (2009)
Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia
Beth Kurt et al.
CANCER (2008)
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias
S Faderl et al.
BLOOD (2005)